Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
Sumimoto H, Noda S, Koide H, Douke Y, Sakai K, Nishikawa A, Tomioka A, Hori M, Nakato H, Kimura Y, Tokuda A, Takano A, Teramoto K, Murata S, Daigo Y.
Sumimoto H, et al. Among authors: koide h.
PLoS One. 2024 Jul 16;19(7):e0306995. doi: 10.1371/journal.pone.0306995. eCollection 2024.
PLoS One. 2024.
PMID: 39012903
Free PMC article.